Loading fund information
Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
The fund’s disclosed portfolio, not an index membership list. Showing the largest 10 positions. The ten largest identified positions carry 98.3% of the portfolio.
| # | Holding | Sector | Country | % of net assets | Filed value |
|---|---|---|---|---|---|
| 1 | DREYFUS GOVERNMENT CASH MANAGE | — | United States | 30.03% | $886.54K |
| 2 | GOLDMAN FINANCIAL | — | United States | 25.54% | $754.07K |
| 3 | ARGENX SE - ADR ARGX | Healthcare | Netherlands | 10.08% | $297.83K |
| 4 | REGENERON PHARMACEUTICALS INC REGN | Healthcare | United States | 8.55% | $252.42K |
| 5 | Amgen Inc. AMGN | Healthcare | United States | 8.53% | $252.07K |
| 6 | VERTEX PHARMACEUTICALS INC VRTX | Healthcare | United States | 8.22% | $242.75K |
| 7 | Gilead Sciences Inc. GILD |
Source: SEC filings. Information and analytics, not investment advice.
| Healthcare |
| United States |
| 8.14% |
| $240.35K |
| 8 | GOLDMAN SACHS LIQ ES FD A | — | United States | 5.42% | $160.00K |
| 9 | N/A | — | United States | -1.51% | -$44.67K |
| 10 | N/A | — | United States | -4.66% | -$137.70K |